There are some interesting volume coming in. here recently. the company has some plans beyond the recent announcement of a merger in Australia. Stay tuned.

I see the volume is gradually moving to the upside. More and more people coming. to understand how artificial intelligence is drastically changing the world of animation., And recently, a very nice report by HANS of DDAmanda.

https://www.tradingview.com/x/KNB1YzVQ/

HI = https://www.tradingview.com/x/KNB1YzVQ/

YES +THIS : https://www.tradingview.com/x/noACxWh1/

HELLO = https://www.tradingview.com/x/85XazrEJ/

https://www.tradingview.com/x/GXVqCutt/

You're not sure why this company would acquire A company with an excellent CEO has to. has expertise in artificial intelligence as it relates to health and Wellness. online ordering?

I saw some very suspicious trading by the market. makers dropping the trade price on lower volume. Let me show you.
Tried to copy and paste, but I can't seem to make it work. We had 40,000 shares at..017.... Then they dropped it to point, 0149 on 15,000 shares.

Hey Mr T storm did you ever consider the fact that perhaps the CEO is busy building the company? looking at. new acquisitions. Do you know how long that takes? Do you know how many members you need on a team to do that? Why don't you leave word with him what you want to speak? about and maybe he'll be more inclined. Yeah, let you know that he'll be back to you within a couple of weeks.

Again, with all due respect I take issue with Tstorm.
IMHO, Company management is Not involved with the daily trading and the technical issues of trading
the stock every day.
In your latest post, you seem to relate the two entities.
By the way. for tea storm and everyone else do you see? informed accumulation in the last week.

https://cdn.discordapp.com/attachments/1065015515837366285/1203062393693929522/image.png?ex=65cfba2a&is=65bd452a&hm=df8a5c5c847d92e44496668007c91653eca61c08b1385c77a971192b382144a1&

LBRG... The fundamental story here is powerful and I think you will be rewarded if you keep a bullish attitude toward the stock even after that short selling bear raid to which we were subjected recently. The recently Acquired subsidiary GROWHOUSE definitely merits some deep research on your part !!!
By the way I've been at this investing business for 60 years and low price Special Situations in the OTC pink space for about 10 years ! You might Remember Me on iHub when I was riding FUSZ from $0.07 to over $3

With all due respect Mr. T storm has things cattywampus

I don't wanna do too much posting on my first day here ,,,but = $LBRG + their recent acquisition Growhouse are using advanced Artificial intelligence
AI makes them a powerhouse +sets them apart in nutrition and pharmaceuticals ....https://twitter.com/stewdomer/status/1722742654679630018/photo/1

$LBRG.... The message is nutraceuticals !!!
CATALYSTS COMING ! ARE YOU POSITIONED ?
Recently acquired Growhouse reported revenues of 2.7 million for the year ending December 31st 2022 and revenue growth of 2.4 million through July 30th. 2023.
MORE GROWTH TO COME

$LBRG
Over the next 24 months, Ladybug will embark on an aggressive growth program characterized by #acquisitions designed to generate additional #revenues of approximately $100k to $300k per month.
Stay updated https://ladybuglbrg.com, https://growhousenutraceuticals.com
Add to your radar

https://smashelito.substack.com/p/es-weekly-plan-april-17-21-2023#:~:text=The%20weekly%20level,day%20balance%20area.

Perhaps like Leonight and other lenders who have converted. Perhaps they will run. The stock bring liquidity to the stock.

The pr's line up....
first there is talk about. Electromedical surrounding. Magic mushrooms....
So the intelligent among us. Rules out recreational magic mushrooms and starts looking at the opportunity. The opportunity in the medical area.
Then we see. An acquisition of AVAIL labs.
Next we see. A PR. About $6 million. Revenue potential in South Florida from the. CEO of a male labs.
Then we see a $25 million line of credit for the. Purchase. Of these electromedical devices, which will allow experts to read the neural pathways in. Suicidal. Veterans. In people who are addicted to heroin, in alcoholics, et cetera,
I am beginning to see. On the wall.
The future for Magic mushrooms. I would say Silocybin, if I could spell it easily.
The future is in medicine, not in recreation. Make note of that. Everybody.

$mobo... I believe the stars are lining up properly. For the. Story on this stock. To be shown to many more people in the next month than in the last three months./
Draw your own conclusions with respect to what might happen with the. vol + the price.

@stewdomer
·
16h
$SINC...market makers are being a pernicious influence.
Ignore what you see ...until
we officially RESUME TRADING

$SINC... Will not reopen again for regular trading for a month and 1/2 due to an audit and then uplist to QB.
Definitely ignore any market - maker prevarications at this time---they are not real trades !
@SincerityCorp

[img]http://www.tradingview.com/x/Xlees6G8/
[/img]

Expert Market to OTCQB
Expert Market from Sept 29, 2022
Dear SINC Investors,



You might have noticed that from Sept 29th, 2022, SINC was placed on Expert Market on OTC, as a result, proprietary quotations were temporarily suspended for SINC.

Reason for SINC been moved to Expert Market
Since 2019, our Ks and Qs were filed with un-audited financials to save costs while we were waiting for our 3a-10 fairness order to close our acquisition.



Issuers on OTC Pink with audited financial are voluntary, and according to PCAOB 4110.4, issuers with unaudited financials can file amendments with audited financials.



We further passed the SEC Rule15c2-11 on September 26, 2021 to remain current until Sept 29, 2022.



The original plan was to file a comprehensive super 10k where the company can include audited financials along with acquisitions and consolidations, as part of NYES/NASDAQ up listing process.



On Sept 29th, 2022, right after market close, OTC market advised us that our reporting needs to have audited numbers included before we can be back on current.

Solution: Stopover Up listing to OTCQB
To fix the issue, quote OTC Market instructions:



"In order to be eligible for proprietary quotations, the company would have to either have a broker file and clear a Form 211 with FINRA or undergo an Initial Review by applying to OTCQX or OTCQB in addition to providing the required filings with the SEC."



FINRA form 211 has uncertainties on timeline, so we have decided to do a stopover OTCQB up listing before NYSE/NASDAQ up listing. The turn around time is expected to be around 4-6 weeks.



It's an unexpected hiccup right before we start consolidating our financials but rest assured, this is being taken care off.



I'll provide further updates soon.



Thank you



Kind Regards,



Yiwen (James) Zhang



CEO

Sincerity Applied Materials Holdings Corp

This was not a punitive measure
this was an accounting measure
when the shares are traded once again TWTR Twitter says the option to edit it. the company will be more robust, you will be then trading on the OTC QB, you will have a recently completed audit, there may be some news from the recently attached investment bank, and there may be some news regarding the status of the acquisition SIMCOR !

$QSAM...Investors are always looking for the next great bioscience company that seeks effective treatment in the ongoing battle against cancer and related diseases.
https://www.tradingview.com/x/B5s0paiI/

Sincerity
@SincerityCorp
·
44m
$SINC was placed on OTC Expert Market from 29th of Sept 2022.
To have the issue fixed we will insert the missing audited numbers in Ks and Qs with amendments, with a combination of listing application to OTCQB.
This would take about 4 - 6 weeks, we will keep public informed.

Qsam Biosciences is an OTC company with loads of potential in that space. The Austin, Texas-based company trades under the symbol $QSAM.

QSAM uses a unique technology CycloSam (Samarium-153 DOTMP) to clinically stage bone targeting radiopharmaceutical which is developed by IsoTherapeutics Group LLC.

Cyclosam is an already FDA-approved drug.

IsoTherapeutics has recently developed Quadramet which is used for pain palliation.

In short, investors need to know that the combination of radioactive isotope and the chelant DOTMP provides a radioactive dose to the sites of mineral turnover such as bone cancers.

Telemed Platform – This is the core system used to build a customized telemedicine management system for clients. Telemed has various components that can assist a company seeking to provide telemedicine services with a secure portal. It is most useful for telemedicine consults with a variety of exam modalities such as neurology, cardiology, neurosurgery, critical care, orthopedics and psychiatry features to document case studies. Telemed can be connected to mobile devices, tablets, laptops and stand- alone desktops.

Investors are always looking for the next great bioscience company that seeks effective treatment in the ongoing battle against cancer and related diseases.



Qsam Biosciences is an OTC company with loads of potential in that space. The Austin, Texas-based company trades under the symbol QSAM.



QSAM uses a unique technology CycloSam (Samarium-153 DOTMP) to clinically stage bone targeting radiopharmaceutical which is developed by IsoTherapeutics Group LLC.



Cyclosam is an already FDA-approved drug.



IsoTherapeutics has recently developed Quadramet which is used for pain palliation.



In short, investors need to know that the combination of radioactive isotope and the chelant DOTMP provides a radioactive dose to the sites of mineral turnover such as bone cancers.



QSAM has a market capitalization of $9.30 million and there are currently 1.69 million shares outstanding.



The 52-week high is $16/share and the 52-week low is $3.50/share.



QSAM currently trades at $5.50.



If you want to learn more about this fascinating targeted therapeutic radiopharmaceutical company, visit QSAM’s web site at www.qsambio.com.

Sincerity is a unique situation inasmuch as it is an ongoing ipo. So the higher the daily trading price the fewer the number of shares which will be issued in the IPO... So an interesting way to look at it is...
the higher the price of the stock, therefore ...the more you grow the SINC earnings per share.

I suggest you keep an eye on the price and if you see any momentum especially over 20 cents 25 cents or 30 cents think about adding to your position.

Sometimes I read the small print usually when I do it's associated with some kind of multi bag or move so the small print here talks about the investment banker advising us on a placement and advising us on and uplist
by the way I'm sure you know that an uplist to the NYSE which is our preference requires a $4 per share stock price on a stock that is now selling at $0.14 in the ongoing IPO IPO

Sincerity
@SincerityCorp
·
17h
SINC enters into definitive agreement with investment bank for consulting and placement agent services.
8K filed with SEC.

https://sec.gov/ix?doc=/Archives/edgar/data/0001532595/000168316822006596/sincerity_8k.htm

$SINC

$SINC - Company Overview
We are a supplier of technologically advanced plastics and other solutions for the packaging industry and other industries primarily serving major end users and distributors in Australia, Asia and the Middle East. Our products have applications in the areas of packaging, agriculture, automotive and transportation, paint and coating, construction, personal care and hygiene, electronics, pharmaceutical, energy and natural resources, plastics and rubber and leather. Our principal products are high quality, breathable plastic film and modified atmosphere packaging used in the packaging of perishable foods.
In 2021, through the acquisition target SIMCOR, SINC expands deeper into our existing customer based in EV, 5G, computer chips and medical industries. In addition, the pandemic boosts the demand for covid related medical material and SINC boosted vaccine related production capacity through SIMCOR

$SINC sincerity Applied Materials. Special situation - PRE-IPO And pre- NASDAQ Uplist opportunity !!!

This company was created to do an IPO Of the privately-traded Chinese company, Simcor = A leader in Engineering plastics.As you know recent IPO's of Chinese private company have been tremendous 2500% gains on some of them!

This is a third generation company in the family of YIWEN "JAMES" Zhang. Rather than the tremendous upfront charges in a normal IPO,James has chosen To bring simcor public Through a 3A10. So, quite simply, We have Infinity fund Creating the Funds for the takeover of Simcor.Again, this was done in place of a normal Wall Street IPO.

The acquisition has been negotiated + all terms agreed to, And the following Highlights pertain:
Simcor guarantees revenues of.$10 million for the first year. And $1,000,000 in net.
Simcor further guarantees a 50% increase in revenues and income for the next two years after the acquisition.
So : four cents the first year, six cents in year two, $0.09 in year 3.
Then, knowing that the PE ratio for publicly traded Engineering Plastics stocks is 50 to 60...

Multiply the .09 times 60 and you have a target price of $5.40. This is without larger growth each year, which is expected... and without Any contributions from Further planned strategic acquisitions.

So what is the suggestion? It is quite simply to start buying the stock in the $0.20 range and All the way up to $0.80. I shall create a further review when we reach $0.80.

Here is the story on Sincerity/Simcor = https://microcaps.com/a-unique-play-in-engineering-plastics-and-green-materials/

And here is the Intrinsic value story = straight from James, The CEO and founder of Sincerity and a third generation member of the Simcor family...= Live Webinar Makeup - Market interact with our 3a10 hedge fund following Intrinsic value

$SINC
A few years back I wrote in my blog " trader haven" that undiscovered gems which could be 10 baggers or better were much more likely to be discovered in the OTC marketplace.
Sincerity is just that = an undiscovered gem.
And when you're looking for better than a10 bagger...Say a 20 - 50 bagger, the stars have to align. And I believe we have that situation here!
1) you have a whip - smart CEO who is ultra compliant + has plans for uplisting.
2) his business plan is modeled after ultra successful Cabot Corp = $CBT
3) his takeover strategy borrows from Elon Musk = in that the owners and managers of the acquisitions are encouraged to stay on and to take less money and more stock for a future payoff. So, SINC acquires these new assets for very little money down which creates dramatic gains in earnings per share.

In this YouTube video the CEO discusses intrinsic value in this ongoing IPO which was created for the purpose of taking over a high tech 30 decade profitable private Chinese company called SIMCOR...
When the IPO takeover is completed and the SIMCOR financials are assimilated by
$SINC.... Then you all have intrinsic value of perhaps $3.80
and mind you, this stock is currently trading at $0.17

$SINC... 9 to 18 bagger !
The market shenanigans continue/ whilst the CEO continues to execute the business plan/ and continues to believe that one day the intrinsic value will be the magnet for the price = $1.80 to $3.60

$SINC...
Fascinating leverage created by the 3a10 SEC exemption IPO being used to acquire simcor, a private space age plastics Chinese company growing like topsy... You can mathematically determine the intrinsic value of the stock and you can invest like the Oracle of Omaha Mr Buffett = intrinsic value investing results in huge gains consistent gains